AUTHOR=Fu Yajie , Zhou Yanzhi , Shen Linhu , Li Xuewen , Zhang Haorui , Cui Yeqi , Zhang Ke , Li Weiguo , Chen Wei-dong , Zhao Shizhen , Li Yunfu , Ye Wenling TITLE=Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease JOURNAL=Frontiers in Pharmacology VOLUME=13 YEAR=2022 URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.973366 DOI=10.3389/fphar.2022.973366 ISSN=1663-9812 ABSTRACT=

The global incidence rate of non-alcoholic fatty liver disease (NAFLD) is approximately 25%. With the global increase in obesity and its associated metabolic syndromes, NAFLD has become an important cause of chronic liver disease in many countries. Despite recent advances in pathogenesis, diagnosis, and therapeutics, there are still challenges in its treatment. In this review, we briefly describe diagnostic methods, therapeutic targets, and drugs related to NAFLD. In particular, we focus on evaluating carbohydrate and lipid metabolism, lipotoxicity, cell death, inflammation, and fibrosis as potential therapeutic targets for NAFLD. We also summarized the clinical research progress in terms of drug development and combination therapy, thereby providing references for NAFLD drug development.